Yohimbine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01392 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | attention deficit-hyperactivity disorder | KG + DL |
| 4 | faciodigitogenital syndrome | KG + DL |
| 5 | migraine with or without aura, susceptibility to | KG + DL |
| 6 | primary hereditary glaucoma | KG + DL |
| 7 | headache disorder | KG + DL |
| 8 | transient ischemic attack (disease) | KG + DL |
| 9 | common cold | KG + DL |
| 10 | open-angle glaucoma | KG + DL |
| 11 | atrophoderma vermiculata | KG + DL |
| 12 | trigeminal autonomic cephalalgia | KG + DL |
| 13 | pulmonary hypertension | KG + DL |
| 14 | ulerythema ophryogenesis | KG + DL |
| 15 | papillary conjunctivitis | KG + DL |
| 16 | kyphoscoliotic heart disease | KG + DL |
| 17 | allergic urticaria | KG + DL |
| 18 | respiratory failure | KG + DL |
| 19 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 20 | trichotillomania | KG + DL |
| 21 | erectile dysfunction (disease) | KG + DL |
| 22 | chondromyxoid fibroma | KG + DL |
| 23 | cold urticaria | KG + DL |
| 24 | Tourette syndrome | KG + DL |
| 25 | specific developmental disorder | KG + DL |
| 26 | glaucoma 1, open angle | KG + DL |
| 27 | phaeochromocytoma | KG + DL |
| 28 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 29 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 30 | nasal cavity disease | KG + DL |
| 31 | cor pulmonale | KG + DL |
| 32 | intracranial arteriosclerosis | KG + DL |
| 33 | congenital hypotrichosis milia | KG + DL |
| 34 | hypotrichosis simplex of the scalp | KG + DL |
| 35 | venous thoracic outlet syndrome | KG + DL |
| 36 | arterial thoracic outlet syndrome | KG + DL |
| 37 | neurogenic thoracic outlet syndrome | KG + DL |
| 38 | vascular disease | KG + DL |
| 39 | diffuse alopecia areata | KG + DL |
| 40 | exercise-induced malignant hyperthermia | KG + DL |
| 41 | sciatic neuropathy | KG + DL |
| 42 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 43 | psychotic disorder | KG + DL |
| 44 | visceral calciphylaxis | KG + DL |
| 45 | familial periodic paralysis | KG + DL |
| 46 | subarachnoid hemorrhage (disease) | KG + DL |
| 47 | bronchial disease | KG + DL |
| 48 | idiopathic and/or familial pulmonary arterial hypertension | KG + DL |
| 49 | open angle glaucoma | KG + DL |
| 50 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.